MedKoo Cat#: 129070 | Name: PF-6142

Description:

WARNING: This product is for research use only, not for human or veterinary use.

PF-6142 is a G protein-biased agonist with β-arrestin signaling and measurable receptor internalization.

Chemical Structure

PF-6142
PF-6142
CAS#N/A

Theoretical Analysis

MedKoo Cat#: 129070

Name: PF-6142

CAS#: N/A

Chemical Formula: C21H16N4O2

Exact Mass: 356.1273

Molecular Weight: 356.39

Elemental Analysis: C, 70.77; H, 4.53; N, 15.72; O, 8.98

Price and Availability

Related CAS #
No Data
Synonym
PF-6142; PF6142; PF 6142
IUPAC/Chemical Name
4-(3-methyl-4-(6-methylimidazo[1,2-a]pyrazin-5-yl)phenoxy)furo[3,2-c]pyridine
InChi Key
HWAIAGZSWHOLLK-UHFFFAOYSA-N
InChi Code
InChI=1S/C21H16N4O2/c1-13-11-15(27-21-17-6-10-26-18(17)5-7-23-21)3-4-16(13)20-14(2)24-12-19-22-8-9-25(19)20/h3-12H,1-2H3
SMILES Code
CC1=C(C2=C(C)N=CC3=NC=CN23)C=CC(OC4=NC=CC5=C4C=CO5)=C1
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 356.39 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

1: Kozak R, Kiss T, Dlugolenski K, Johnson DE, Gorczyca RR, Kuszpit K, Harvey

BD, Stolyar P, Sukoff Rizzo SJ, Hoffmann WE, Volfson D, Hajós M, Davoren JE,

Abbott AL, Williams GV, Castner SA, Gray DL. Characterization of PF-6142, a

Novel, Non-Catecholamine Dopamine Receptor D1 Agonist, in Murine and Nonhuman

Primate Models of Dopaminergic Activation. Front Pharmacol. 2020 Jul 7;11:1005.

doi: 10.3389/fphar.2020.01005. PMID: 32733245; PMCID: PMC7358525.

 

2: Nguyen AM, Semeano A, Quach V, Inoue A, Nichols DE, Yano H. Characterization

of Gα<sub>s</sub> and Gα<sub>olf</sub> activation by catechol and non-catechol

dopamine D1 receptor agonists. iScience. 2025 Apr 3;28(5):112345. doi:

10.1016/j.isci.2025.112345. PMID: 40384932; PMCID: PMC12084000.